166 related articles for article (PubMed ID: 17072983)
21. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
22. Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.
Sho M; Murakami Y; Motoi F; Satoi S; Matsumoto I; Kawai M; Honda G; Uemura K; Yanagimoto H; Kurata M; Fukumoto T; Akahori T; Kinoshita S; Nagai M; Nishiwada S; Unno M; Yamaue H; Nakajima Y
J Gastroenterol; 2015 Jun; 50(6):694-702. PubMed ID: 25341657
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic ductal adenocarcinoma and paraaortic lymph nodes metastases: The accuracy of intraoperative frozen section.
Doussot A; Bouvier A; Santucci N; Lequeu JB; Cheynel N; Ortega-Deballon P; Rat P; Facy O
Pancreatology; 2019 Jul; 19(5):710-715. PubMed ID: 31174978
[TBL] [Abstract][Full Text] [Related]
24. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
25. The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.
Wang LM; Silva MA; D'Costa Z; Bockelmann R; Soonawalla Z; Liu S; O'Neill E; Mukherjee S; McKenna WG; Muschel R; Fokas E
Oncotarget; 2016 Jan; 7(4):4183-94. PubMed ID: 26716653
[TBL] [Abstract][Full Text] [Related]
26. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.
La Torre M; Nigri G; Petrucciani N; Cavallini M; Aurello P; Cosenza G; Balducci G; Ziparo V; Ramacciato G
Pancreatology; 2014; 14(4):289-94. PubMed ID: 25062879
[TBL] [Abstract][Full Text] [Related]
27. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
[TBL] [Abstract][Full Text] [Related]
28. The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy.
Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Anticancer Res; 2018 Aug; 38(8):4877-4882. PubMed ID: 30061263
[TBL] [Abstract][Full Text] [Related]
29. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis.
Passlick B; Izbicki JR; Kubuschok B; Thetter O; Pantel K
Ann Thorac Surg; 1996 Jan; 61(1):177-82; discussion 183. PubMed ID: 8561549
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma: effect on tumor cell microinvolvement of regional lymph nodes.
Becker K; Fumagalli U; Mueller JD; Fink U; Siewert JR; Höfler H
Cancer; 1999 Apr; 85(7):1484-9. PubMed ID: 10193937
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic cancer: a generalized disease--prognostic impact of cancer cell dissemination.
Bogoevski D; Strate T; Yekebas EF; Izbicki JR
Langenbecks Arch Surg; 2008 Nov; 393(6):911-7. PubMed ID: 18202848
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant Chemotherapy Enhances Local Postoperative Histopathological Tumour Stage in Borderline Resectable Pancreatic Cancer - A Matched-Pair Analysis.
Timmermann L; Rosumeck N; Klein F; Pratschke J; Pelzer U; Bahra M; Malinka T
Anticancer Res; 2019 Oct; 39(10):5781-5787. PubMed ID: 31570482
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.
Izbicki JR; Hosch SB; Pichlmeier U; Rehders A; Busch C; Niendorf A; Passlick B; Broelsch CE; Pantel K
N Engl J Med; 1997 Oct; 337(17):1188-94. PubMed ID: 9337377
[TBL] [Abstract][Full Text] [Related]
34. Implication of thymidylate synthase in the outcome of patients with invasive ductal carcinoma of the pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil or its derivatives.
Takamura M; Nio Y; Yamasawa K; Dong M; Yamaguchi K; Itakura M
Anticancer Drugs; 2002 Jan; 13(1):75-85. PubMed ID: 11914644
[TBL] [Abstract][Full Text] [Related]
35. Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer.
Malleo G; Maggino L; Capelli P; Gulino F; Segattini S; Scarpa A; Bassi C; Butturini G; Salvia R
J Am Coll Surg; 2015 Aug; 221(2):367-79.e4. PubMed ID: 26081176
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
37. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
[TBL] [Abstract][Full Text] [Related]
38. Should a standard lymphadenectomy include the No. 9 lymph nodes for body and tail pancreatic ductal adenocarcinoma?
Zhou Y; Lin J; Wang W; Chen H; Deng X; Peng C; Cheng D; Shen B
Pancreatology; 2019 Apr; 19(3):414-418. PubMed ID: 30902419
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome.
Baldwin S; Kukar M; Gabriel E; Attwood K; Wilkinson N; Hochwald SN; Kuvshinoff B
HPB (Oxford); 2016 Jun; 18(6):523-8. PubMed ID: 27317957
[TBL] [Abstract][Full Text] [Related]
40. Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma.
Scheunemann P; Stoecklein NH; Rehders A; Bidde M; Metz S; Peiper M; Eisenberger CF; Schulte Am Esch J; Knoefel WT; Hosch SB
Langenbecks Arch Surg; 2008 May; 393(3):359-65. PubMed ID: 17704938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
